Company Information
CIN
Status
Date of Incorporation
04 October 2004
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
100,000
Authorised Capital
600,000
Directors
Sudhir Banarsilal Tulsyan
Director/Designated Partner
about 2 years ago
about 2 years ago
Anurag Sudhir Tulsyan
Director
about 21 years ago
about 21 years ago
Past Directors
Deepti Anurag Tulsyan
Additional Director
almost 4 years ago
almost 4 years ago
Adrian Henry Almeida
Director
about 21 years ago
about 21 years ago
Patents
ABSTRACT
The present invention relates to an alternative and cost effective RP HPLC method for analysis of amino acids in protein hydrolysates samples, more specifically monoclonal antibody hydrolysates. The method of the present invention comprises hydrolysis of the protein/monoclonal antibody samples to obtain a ...
Registered Trademarks
[Class : 1] Chemicals For Use In Industry And Science , Artificial Sweeteners , Diagnostic Preparations, Other Than For Medical Or Veterinary Purposes , Chemical Supplements For Use In The Manufacture Of Vitamins , Chemical Additives For Food , Food Preservative Compositions , Flavour Improvers For Foodstuffs.
[Class : 1] Chemicals For Use In Industry And Science , Artificial Sweeteners , Diagnostic Preparations, Other Than For Medical Or Veterinary Purposes , Chemical Supplements For Use In The Manufacture Of Vitamins , Chemical Additives For Food , Food Preservative Compositions , Flavour Improvers For Foodstuffs.
[Class : 44] Testing And Analysis For Use In Connection With Medical, Pharmaceutical, Chemical And Biological Services, Medical Analysis , Information Relating To Testing And Analysis For Use In Connection With Medical, Pharmaceutical, Chemical And Biological Services.
View +4 more Brands for Zelle Biotechnology Private Limited.
Documents
Form DPT-3-08122020-signed
Form DPT-3-19082020-signed
Form MGT-14-22102019_signed
Directors report as per section 134(3)-22102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-22102019
List of share holders, debenture holders;-22102019
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-22102019
Optional Attachment-(1)-22102019
Form AOC-4-22102019_signed
Form MGT-7-22102019_signed
Form ADT-1-14102019_signed
Optional Attachment-(1)-11102019
Copy of the intimation sent by company-11102019
Optional Attachment-(2)-11102019
Copy of written consent given by auditor-11102019
Copy of resolution passed by the company-11102019
Form DPT-3-28062019
Form MSME FORM I-30052019_signed
Form ADT-1-11102018_signed
Form AOC-4-11102018_signed
Form MGT-7-11102018_signed
Copy of written consent given by auditor-10102018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-10102018
Optional Attachment-(1)-10102018
Copy of the intimation sent by company-10102018
Directors report as per section 134(3)-10102018
Copy of resolution passed by the company-10102018
List of share holders, debenture holders;-10102018
Optional Attachment-(2)-10102018
Form MGT-7-16102017_signed
